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Abstract
Background: Caroli's disease (CD) is a rare congenital disorder. The early diagnosis of the disease and
differentiation of types I and II are of extreme importance to patient survival. This study was designed to
review and discuss observations in 30 patients with CD and to clarify the clinical characteristics of the
disease.
Methods: The demographic and clinical features, laboratory indicators, imaging findings and pathology
results for 30 patients with CD were reviewed retrospectively.
Results: Caroli's disease can occur at any age. The average age of onset in the study cohort was
24 years. Patients who presented with symptoms before the age of 40 years were more likely to develop
type II CD. Approximately one-third of patients presented without positive signs at original diagnosis and
most of these patients were found to have type I CD on pathology. Anaemia, leucopoenia and
thrombocytopoenia were more frequent in patients with type II than type I CD. Magnetic resonance
cholangiopancreatography (MRCP) and computed tomography (CT) examinations were most useful in
diagnosing CD.
Conclusions: No typical symptoms, signs or laboratory indicators are able to distinguish CD from other
conditions. Both MRCP and CT were most valuable in diagnosis. The two types of CD may be differen-
tiated by age of onset and routine blood tests.
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Introduction
Caroli’s disease (CD), also known as communicating cavernous
ectasia or congenital saccular dilatation of the intrahepatic bile
ducts, is a rare congenital disorder first specifically described in
1958.1 It is characterized by multifocal segmental dilatation of the
intrahepatic bile ducts, involving the entire liver, a lobe or a single
segment, while these ducts remain connected with the main duct
system.2–5 The disease is also characterized by the formation of
intraductal calculi and susceptibility to infection.1
Two types of CD were later recognized. Type I, or simple CD,
consists of pure cystic dilatations of the intrahepatic bile ducts,
whereas type II, or complex CD, also known as Caroli’s syndrome
(i.e. CD with congenital hepatic fibrosis), is associated with
hepatic fibrosis, or even cirrhosis, portal hypertension and
oesophageal varices.6 Type II CD may be accompanied by
cholangiocarcinoma, calculi of the intrahepatic duct, cholangitis,
pancreatic cyst, renal cystic disease or medullary sponge kidney.7
It has even been regarded as precancerous and patients with type
II CD are reported to have a 2.5–17.5% likelihood of developing
cholangiocarcinoma,8 which is 100-fold higher than in subjects
with normal hepatobiliary ducts and 10-fold higher than in those
with calculi.9 However, CD has no specific symptoms or signs,
which makes diagnosis difficult. Its incidence is extremely low at
one case per 1 000 000 people.10 The present study was conducted
to clarify the clinical characteristics of this disease through a retro-
spective review of symptoms, signs, laboratory indicators,
imaging results and pathologic findings in 30 patients with CD
treated at the study institution.
Materials and methods
Between January 2009 and May 2013, 30 patients with CD were
admitted to the 302 Hospital, Beijing. Patient data were collected
from the patients’ medical records and covered: demographic*These authors contributed equally to this work.
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characteristics, including age, sex, age at onset of CD, and
family history; clinical symptoms and signs; laboratory
indicators, including results of routine blood tests and biochemi-
cal markers; findings on imaging modalities, including ultra-
sonography, computed tomography (CT), magnetic resonance
cholangiopancreatography (MRCP), magnetic resonance imaging
(MRI) and endoscopic retrograde cholangiopancreatography
(ERCP); pathology results, and details of any associated condi-
tions. The diagnosis of CD was based on imaging results obtained
in the study hospital and was confirmed by histopathology. All
patients were evaluated by the same pathologist.
All statistical analyses were performed using spss for Windows
Version 13.0 (SPSS, Inc., Chicago, IL, USA). Categorical variables
were analysed using the chi-squared test or logistic regression, and
continuous variables were reported as the mean or median, as
appropriate. A P-value of <0.05 was considered to indicate statis-
tical significance.
Results
Demographic features
The 30 patients with CD included 11 males and 19 females
(male : female ratio: 1 : 1.7) with a mean age of 24 years (range:
3 months to 82 years). Of these patients, eight were aged
0–6 years, seven were aged 7–17 years, nine were aged 18–40 years,
five were aged 41–65 years, and one was aged > 66 years. Patients
who presented with symptoms before the age of 40 years were
significantly more likely to have type II than type I CD (P = 0.028)
(Table 1). Of these 30 patients, only three (10.0%) had a family
history of liver cirrhosis or variceal haemorrhage.
Histopathology
Liver biopsy samples were taken from all 30 patients. The type of
histopathology performed depended on the presence or absence
of hepatic fibrosis and portal hypertension. Type I, or simple CD,
is characterized by saccular or cystic dilatation of the segmental
intrahepatic bile ducts, with the duct walls lined by hyperplastic or
ulcerated biliary epithelium. The colour and texture of the hepatic
parenchyma are normal, although fibroplasia is present in the
dilated bile ducts, which contain inflammatory cell infiltrates
(Fig. 1). Type II CD, or Caroli’s syndrome, is characterized by
hepatic and dense portal fibrosis, along with dilated bile ducts.
The fibrotic regions contain variable numbers of abnormally
shaped bile ducts and hypoplastic portal vein branches, and the
hepatic parenchyma is subdivided by the overgrowth of portal
fibrous tissue, with no evident parenchymal regenerative activity
(Fig. 2). In addition, secondary cirrhosis may be found in patients
with more severe type II CD.11
Of the 30 patients, nine were diagnosed with type I CD, includ-
ing three who also had chronic cholangitis, and 21 were diagnosed
with type II CD, including 14 with cirrhosis and two with biliary
cirrhosis.
Table 1 Age profile of the 30 patients with Caroli's disease (CD)
types I and II
Age, years
0–6 7–17 18–40 41–65 > 66
Patients with type I CD, n 3 1 1 3 1
Patients with type II CD, n 5 6 8 2 0
Figure 1 Histopathology of a liver biopsy from a patient with
type I Caroli's disease shows cystic dilatation of the segmental
intrahepatic bile ducts. (Haematoxylin and eosin stain; original
magnification ×10)
Figure 2 Histopathology of a liver biopsy from a patient with type II
Caroli's disease shows hepatic and dense portal fibrosis, along
with dilated bile ducts. (Haematoxylin and eosin stain; original
magnification ×10)
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Presentations
Symptoms
The most frequent initial symptoms of the disease in the present
patients included right upper quadrant pain (n = 14, 46.7%), fever
(n = 11, 36.7%), anorexia (n = 8, 26.7%), variceal bleeding
(haematemesis, melaena or haematochezia; n = 8, 26.7%), fatigue
(n = 6, 20.0%), and jaundice (n = 5, 16.7%). Of the 11 patients
with fever, only three (27.3%) had low-grade fever (<38 °C),
whereas the other eight (72.7%) had high fever (39–40 °C). Less
frequent symptoms included diarrhoea in one patient, and nausea
and vomiting, skin itch, and oedema of the lower limbs in two
patients each. Four patients were completely asymptomatic and
were diagnosed during a health examination conducted for other
reasons (Table 2). There were no differences in the frequency of
symptoms between patients with types I and II CD (P > 0.05).
Signs
On physical examination, 10 patients (33.3%) presented with no
signs of CD at the time of first diagnosis; this was more common
in type I patients (P = 0.011). Common signs in the present series
included hepatosplenomegaly (n = 8, 26.7%), shifting dullness or
jaundice (n = 5, 16.7%), and hepatomegaly or splenomegaly (n =
4, 13.3%) (Table 2). There were no differences in the frequency of
signs between patients with types I and II CD (P > 0.05).
Laboratory indicators
Findings showed that laboratory indicators were able to distin-
guish between the two types of CD. A review of the complete
blood counts (CBCs) of the 30 patients, including their white
blood cell (WBC), red blood cell (RBC) and platelet counts,
showed that 13 (43.3%) patients had pancytopoenia, five (16.7%)
had anaemia, and one (3.3%) had both leucopoenia and
thrombocytopoenia, whereas 11 (36.7%) had normal blood cell
counts. Pancytopoenia (P = 0.020), anaemia (P = 0.002) and com-
bined leucopoenia and thrombocytopoenia (P = 0.011) were
significantly more frequent in patients with type II than type I CD.
Liver function and electrolytes were also reviewed, including
concentrations of albumin, total bilirubin, alanine
aminotransferase (ALT), aspartate aminotransferase (AST), alka-
line phosphatase (ALP), total bile acids (TBA), γ-glutamyl
transpeptidase (GGT), cholinesterase, and potassium (K+),
sodium (Na+) and chloride (Cl−) ions. Decreased albumin,
cholinesterase and K+ were observed in 12 (40.0%), 15 (50.0%)
and seven (23.3%) patients, respectively, and mildly elevated total
bilirubin, ALT, AST, ALP, GGT and TBA in 13 (43.3%), 14
(46.7%), 14 (46.7%), 12 (40.0%), 11 (36.7%) and five (16.7%)
patients, respectively. The frequency of marker abnormalities,
however, did not differ between patients with type I and those
with type II CD (P > 0.05) (Table 3).
Table 2 Clinical symptoms and signs in the 30 patients with
Caroli's disease
n (%)
Symptoms
Right upper quadrant pain 14 (46.7%)
Fever 11 (36.7%)
Anorexia 8 (26.7%)
Variceal bleeding 8 (26.7%)
Fatigue 6 (20.0%)
Jaundice 5 (16.7%)
None 4 (13.3%)
Nausea and vomiting 2 (6.7%)
Itch of skin 2 (6.7%)
Oedema of lower limbs 2 (6.7%)
Diarrhoea 1 (3.3%)
Signs
None 10 (33.3%)
Hepatosplenomegaly 8 (26.7%)
Ascites 5 (16.7%)
Jaundice 5 (16.7%)
Hepatomegaly 4 (13.3%)
Splenomegaly 4 (13.3%)
Liver palm 2 (6.7%)
Oedema of lower limbs 1 (3.3%)
Lymphadenectasis 1 (3.3%)
Table 3 Laboratory indicators in the 30 patients with Caroli's
disease (CD)
Laboratory indicators Patients with
type I CD
(n = 9), n
Patients with
type II CD
(n = 21), n
Complete blood counts
Pancytopoenia 1 12
Anaemia 1 4
Leucopoenia and
thrombocytopoenia
0 1
Normal blood cells 7 4
Liver function
Decreased albumin 3 9
Elevated alanine
aminotransferase
6 8
Elevated aspartate
aminotransferase
5 9
Elevated total bilirubin 5 8
Elevated alkaline phosphatase 4 8
Elevated γ-glutamyl
transpeptidase
4 7
Elevated total bile acids 2 3
Decreased cholinesterase 5 10
Electrolytes
Decreased potassium (K+) 4 3
Abnormal sodium (Na+) 0 0
Abnormal chloride (Cl−) ions 0 0
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Imaging
Of the 30 patients, 22 were examined by ultrasound, 14 by CT, 13
by MRCP, and nine by MRI. The accuracies of these imaging
modalities in diagnosing CD were 27.3%, 71.4%, 84.6% and
77.8%, respectively (Table 4), and showed no differences between
the two types of CD. Imaging diagnosed cirrhosis in 18 patients,
most of whom had type II CD (P = 0.006), which suggests its value
in differentiating between the two types.
Associated conditions
Various conditions were associated with CD. For example, 14
(46.7%) patients had cirrhosis, 11 (36.7%) had renal cysts,
10 (33.3%) had hepatic cysts and seven (23.3%) had
cholangiolithiasis. In addition, three (10.0%) patients had
cholangitis and three (10.0%) had polycystic kidney, two (6.7%)
had polycystic liver, one (3.3%) had pancreatitis, one (3.3%) had
septicaemia and one (3.3%) had medullary sponge kidney.
Discussion
Caroli’s disease is a rare, autosomally recessive inherited congeni-
tal disorder associated with an incomplete and faulty remodelling
of the embryonic ductal plate.12–15 It is usually diagnosed during
childhood or adolescence,16 but may be diagnosed in adult-
hood.17,18 Patients who present with symptoms of CD before the
age of 40 years are more likely to have type II than type I CD. No
gender predominance has been observed,19 including in the
present study.
Clinically, CD has no distinguishing symptoms or signs.
Patients may remain asymptomatic or may experience symptoms
infrequently throughout life.9 Intrahepatic ductal ectasia predis-
poses to stagnation of the bile, which may lead to the formation of
stones and predispose to infections such as cholangitis.10,16 The
most frequent symptoms are right upper quadrant pain, fever and
jaundice. In the present series 72.7% of patients had a high fever of
39–40 °C. Patients may also present with anorexia and fatigue,
often accompanied by severe infections such as abscesses or sep-
ticaemia. Repeated cholangitis predisposes to calculi of the
intrahepatic ducts, which may aggravate bile obstruction and lead
to biliary cirrhosis, as observed in two of the present patients.
Variceal bleeding and ascites have also been observed in patients
with type II CD. Although no differences in signs or symptoms
between patients with types I and II CD were observed in the
present study, patients with type I were more likely to lack any
positive signs.
The diagnosis of CD and differentiation between the two
types depend on laboratory, imaging and pathology examina-
tions. Although differences between laboratory indicators were
observed, they were relatively non-specific. Pancytopoenia,
anaemia, and leucopoenia and thrombocytopoenia were more
likely in type II than in type I patients, thereby differentiating
between these two types of CD. Histopathologic examination
can yield a definitive diagnosis, but liver biopsy is invasive and
can cause injuries. Thus, the diagnosis of CD relies mostly on
imaging modalities, such as ultrasound, CT, MRI and MRCP. In
addition, the present authors found that imaging was able to
differentiate type II CD successfully when the patient developed
cirrhosis.
On ultrasound, CD appears as intrahepatic cystic anechoic
areas, which may include fibrovascular bundles, stones and linear
bridging or septa. The fibrovascular bundles are composed of
portal veins and hepatic arteries, as shown by Doppler ultrasonog-
raphy.9 Despite the ability of ultrasound to visualize liver cysts and
possible intrahepatic lithiasis and to provide information on the
common bile duct, it remains difficult to differentiate cysts arising
from CD from liver cysts arising from other conditions, such as
polycystic liver disease.20 In the present study, ultrasound was
found to have an accuracy of 27.3%, which is much lower than
those of other imaging modalities. Computed tomography scans
may show central dots (Fig. 3a) in CD patients, representing a sign
that is specific and essential, and indicates fibrovascular bundles
containing the portal vein radical and a branch of the hepatic
artery bridging the saccule.20 However, central dots may not
always be present as the accuracy of CT was found to be 71.4%.
Magnetic resonance imaging was not more advantageous than CT
and had an accuracy of 77.8%. The highest level of sensitivity in
the diagnosis of CD was associated with ERCP,21 which suggests
that this method can evaluate the entire biliary tree while also
identifying any intrahepatic masses.22 Imaging by MRCP may
show the connections between the secular ectasias and the normal
biliary tract (Fig. 3b), thus establishing a diagnosis of CD and
ruling out other conditions such as multiple liver abscesses and
polycystic liver disease.20 There are also substantial additional
therapeutic benefits to be gained by using ERCP to assess preop-
erative transient recovery from acute episodes of cholangitis.23
However, because it is invasive and carries a risk for infection,
Table 4 Results of imaging examinations in the 30 patients with Caroli's disease (CD)
Imaging modality Patients
examined, n
Patients diagnosed with
CD by this modality, n
Accuracy,
%
Ultrasound 22 6 27.3%
Computed tomography 14 10 71.4%
Magnetic resonance cholangiopancreatography 13 11 84.6%
Magnetic resonance imaging 9 7 77.8%
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ERCP is superfluous and should not be performed in patients
with established diagnoses.
The treatment of patients with CD depends on the clinical
features of the disease and the locations of biliary abnormalities.
Localized forms, involving either the left or the right half of the
liver, should be treated by hemi-hepatectomy, following obstruc-
tion of the biliary tract or cholangitis. Diffuse involvement of both
lobes can be treated conservatively, including with endoscopic
therapy and an internal biliary bypass procedure,24 but patients
with such involvement are often difficult to manage. Liver trans-
plantation may be the optimal management option in these
patients, even if they are asymptomatic.20 Survival after liver trans-
plantation was found to be poor in patients with congenital
hepatic fibrosis (Caroli’s syndrome) and in those with cholangitis
at the time of orthotopic liver transplantation.25 Although a recent
multicentre study on the longterm results of the surgical manage-
ment of patients with either Caroli’s disease or syndrome showed
encouraging results in terms of postoperative mortality and 5-year
overall survival, the poor prognosis and the sizeable morbidity
and mortality rates after liver transplantation still suggest that the
timely recognition of indications for surgical treatment is of
major importance.26 Thus, the early diagnosis of the disease and
differentiation between types I and II are of extreme importance
to patient survival.
Conclusions
Caroli’s disease is an inherited disorder that may cause severe,
life-threatening cholangitis or hepatobiliary degeneration, or even
cancer.27 Despite its rare incidence, CD should not be forgotten in
the differential diagnosis of patients with recurrent cholangitis.
The onset of CD can occur at any age and in either sex, although
patients who present with symptoms before the age of 40 years
were found to be more likely to have type II CD, or Caroli’s
syndrome. There are no specific symptoms or signs with which to
distinguish the two types of CD, although positive signs are infre-
quently encountered in type I patients during physical examina-
tions. Laboratory findings cannot be relied upon for diagnosis,
although reduced blood cell counts suggest type II CD. The
imaging modalities most useful in the diagnosis of CD are MRCP
and CT.
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